GLP-1 for weight loss works by mimicking a hormone your body naturally produces called glucagon-like peptide-1
Early-phase clinical trial data, including results from a Phase 2 trial published in The New England Journal of Medicine in 2023, demonstrated substantial weight reductions in some participants exceeding 20% of body weight over 48 weeks alongside a broadly manageable short-term adverse effect profile
Specifically, in each of these cases, FDA was able to observe serious regulatory violations based only on a review of the companies websites and social media posts
Related reading on PlexusDx: What Is GLP-1, GLP-1 What Is, GLP-1 Receptor Agonist, GLP-1 Drugs
Last year, the company took the initiative to drive engagement with manufacturers to bend the cost curve similar to how weve helped improve affordability for drugs used for diabetes, high cholesterol, psoriasis, rheumatoid arthritis and many more